# Shari Pilon-Thomas

Source: https://onco.cc/people/shari-pilon-thomas/  
OnCo record `shari-pilon-thomas` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Shari Pilon-Thomas is the immunologist behind Moffitt's TIL manufacturing and the biology of who responds.

## Summary

Shari Pilon-Thomas is a Senior Member in Immunology and Scientific Director of Cellular Therapy at Moffitt Cancer Center. She is the immunologist behind Moffitt's tumour-infiltrating lymphocyte manufacturing and the biology of who responds to it, leading translational immunology for the centre's TIL and cell therapy programmes. Her selected paper shows that neutralising tumour acidity improves anti-tumour responses to immunotherapy. She continues to study tumour acidity and resistance to immunotherapy in melanoma.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Senior Member, Immunology; Scientific Director, Cellular Therapy
- Specialisms: TIL therapy; Tumour immunology; Immunotherapy resistance

## Sources

- Moffitt profile: https://www.moffitt.org/research-science/researchers/shari-pilon-thomas/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Pilon-Thomas%20S%5BAuthor%5D

## Connected records

- cancers: [Melanoma](https://onco.cc/cancers/melanoma/)
- technologies: [TIL therapy](https://onco.cc/technologies/til-therapy/)
- institutions: [Moffitt Cancer Center](https://onco.cc/institutions/moffitt/)
- journals: [Cancer Research](https://onco.cc/journals/cancer-research/)

---
JSON: https://onco.cc/api/v1/entities/shari-pilon-thomas.json